Close Menu
Home » Qiagen Partners With Illumina on NGS IVD Kits; CEO Departing; Preliminary Q3 Revenue Growth Lowered

Qiagen Partners With Illumina on NGS IVD Kits; CEO Departing; Preliminary Q3 Revenue Growth Lowered

Oct 07, 2019
|
staff reporter

NEW YORK – Illumina and Qiagen today announced a 15-year partnership to develop next-generation sequencing-based in vitro diagnostic kits, including companion diagnostics. The deal accompanied announcements that Qiagen CEO Peer Schatz would step down and that the firm has lowered its third quarter sales growth expectations.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Nobel Representation

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Bill to Address Foreign Influence

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Promising, But More Needed

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

Cell Studies Tackle Tissue Clones, Ocean Microbes, Polygenic Trait Prediction

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Sequencing

  1. Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

  2. Abu Dhabi Teams Up With BGI, Oxford Nanopore for Population Sequencing Project

  3. At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

  4. Forensic Genomics Firm Verogen Acquires Genealogy Website GEDmatch

  5. ASH Study Points to Distinct AML, MDS Subtypes Based on Genomic, Transcriptomic Analysis

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.